Effects of losartan on insulin sensitivity in hypertensive subjects

Hypertension

Volumn 28, Issue 3, 1996, Pages 392-396

  Laakso, Markku ^a,b   Karjalainen, Leena ^a   Lempiäinen Kuosa, Päivi ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

glucose; insulin; losartan; metoprolol

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; GLUCOSE; INSULIN; LOSARTAN; METOPROLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; HYPERTENSION; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BLOCKING;

EID: 0029843190     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.392     Document Type: Article

References (22)

1. Kaplan NM. The deadly quartet. Arch Intern Med. 1989;149: 1514-1520.
2. Ferrannini E, Haffner SM, Stern MP, Mitchell BD, Natali A, Hazuda HP, Patterson JK. High blood pressure and insulin resistance: influence of ethnic background. Eur J Clin Invest. 1991;21:280-287.
3. Lithell HOL. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care. 1991;14:203-209.
4. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:206-251.
5. Fouad-Tarazi FM. Hemodynamic effects of inhibitors of the reninangiotensin system. J Hypertens. 1994;12(suppl 2):S25-S29.
6. Moan A, Risanger T, Eide I, Kjeldsen SE. The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous System activity in primary hypertension. Blood Pressure. 1994;3: 185-188.
7. World Health Organization. Diabetes Mellitus. Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985:10-20. Technical Report Series No. 727.
8. DeFronzo RA, Tobin JE, Andres R. Glucose clamp techniques: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
9. Laakso M, Uusitupa M, Takala J, Majander H, Reijonen T, Penttilä I. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metabolism. 1988;37:1092-1100.
10. Ferrannini E. The theoretical bases of indirect calorimetry. Metabolism. 1988;37:287-301.
11. Penttilä IM, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytical and precipitation methods for the direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest. 1984;41:353-360.
12. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis. 1990;10:223-231.
13. Hawk PB, Oser BL, Summerson WH. Practical Physiological Chemistry. 12th ed. Toronto, Canada: Blakiston; 1947:814-822.
14. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993;137:959-965.
15. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT, Karhapää P. Asymptomatic atherosclerosis and insulin resistance. ArteriosclerThromb. 1991;11:1068-1076.
16. Tomiyama H, Kushiro T, Abeta H, Ishii T, Takahashi A, Furukawa L, Asagami T, Hino T, Saito F, Otsuka Y, Kurumatani H, Kobayashi F, Kanmatsuse K, Kajiwara N. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension. 1994;23:450-455.
17. Prager R, Wallace P, Olefsky JM. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest. 1986;78:472-481.
18. Karhapää P, Uusitupa M, Voutilainen E, Laakso M. Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia. Clin Pharmacol Ther. 1992;52: 620-626.
19. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrinol Rev. 1985;5:45-86.
20. de Zeeuw D, Gansevoort RT, Dullaart RPF, de Jong PE. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome. J Hypertens. 1995;13(suppl 1):S53-S58.
21. Laakso M, Edelman SV, Brectel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest. 1990;85: 1844-1852.
22. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark LA. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.